GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ)
$73.83 0.65 (0.8882%)
Analysed GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) News Sources
RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data
13-04-2026
yahoo.com
GE HealthCare Ultrasound Link With Medtronic Adds New Neurosurgery Angle
11-04-2026
yahoo.com
Medtronic Neurosurgery Imaging Tie Up May Influence Digital Surgery Valuation
10-04-2026
yahoo.com
GEHC Unifies bkActiv With Stealth AXiS for Live Neurosurgery Imaging
10-04-2026
yahoo.com
The GE Family Divided: Comparing Valuations, Growth Rates, and Analyst Sentiment Across 3 Sectors
09-04-2026
247wallst.com
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
09-04-2026
yahoo.com
RegASK & Veeva Systems Partner to Boost RIM Intelligence Capabilities
09-04-2026
yahoo.com
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
09-04-2026
yahoo.com
BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension
09-04-2026
yahoo.com
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
09-04-2026
yahoo.com
What is the current price of GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ)?
The current price of GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) is $73.83.
GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) absolute price change since previous trading day?
The absolute price change of GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) since the previous trading day is $0.65.
GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) percentage price change since previous trading day?
The percentage price change of GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) since the previous trading day is 0.8882%.
What is the most recent average sentiment score for GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ)?
The most recent average sentiment score for GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ)?
The most recent sentiment for GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ) is .
SEC-8K** Filing Available For GE HEALTHCARE TECHNOLOGY (GEHC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.